Clorox Q1 FY27: Net Earnings $170M, Gross Margin Down 130 bps, Stockholders' Equity Turns Negative
CLX sits 16% above its 52-week low of $79.12.
Summary
Clorox's Q1 FY27 10-Q shows net earnings of $170 million on $1.91 billion in sales, but gross margin fell 130 basis points and stockholders' equity slipped to a $(39) million deficit after debt-funded GOJO acquisition costs.
Key Events · Earnings and Guidance · CLX
-
Q1 Earnings Double on Easy Comparison
Net earnings attributable to Clorox were $170 million, or $1.39 diluted per share, versus $80 million and $0.65 a year ago; net sales rose 33% to $1,905 million from $1,429 million.
-
Gross Margin Falls 130 Basis Points
Gross margin declined to 40.4% from 41.7% on higher commodity, manufacturing and logistics costs, partly offset by volume and cost savings; gross profit still rose 29% to $770 million on the higher sales base.
-
Stockholders' Equity Turns Negative
Total Clorox stockholders' equity fell to a $(39) million deficit from $90 million at June 30, and current liabilities exceeded current assets by $1,023 million, primarily due to $1,175 million of commercial paper borrowings.
-
Interest Expense Nearly Doubles
Interest expense rose to $52 million from $23 million, driven by incremental borrowings to fund the $2,147 million GOJO acquisition completed April 1, 2026.
Analysis · CLX · Industrial Applications And Services
The headline numbers were already out via the same-day 8-K, but the 10-Q is where the balance sheet gets ugly: total Clorox stockholders' equity flipped to a $(39) million deficit from $90 million at June 30, and current liabilities exceed current assets by $1,023 million, driven by $1,175 million of commercial paper used to fund the GOJO acquisition and the Venture Agreement termination payment. Interest expense nearly doubled to $52 million from $23 million, and gross margin fell 130 basis points to 40.4% on higher commodity, manufacturing and logistics costs. The offset is real: net earnings attributable to Clorox were $170 million versus $80 million, helped by a 16.4% effective tax rate versus 23.4% after an international legal entity reorganization. The company says it has $1,964 million of revolving credit available and is in compliance with its 4.0x interest coverage covenant, so this is a leveraged balance sheet rather than a liquidity crisis — but the equity deficit and negative working capital are the numbers that matter for how much room management has.
How filings like this one have moved
In the 30 days to Nov 8, 2026, 36.3% of the 2976 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLX was trading at $92.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $10.9B. The 52-week trading range was $79.12 to $128.90. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.